Gyan E, Minden MD, Kubo K, Rambaldi A, et al. Maintenance therapy with the FMS-like tyrosine kinase 3 inhibitor gilteritinib in patients with FMS-like tyrosine kinase 3-internal tandem duplication acute myeloid leukemia: A phase 2 study. Cancer 2025;131:e35746.
PMID: 39945223